These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8933355)
21. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release. Song X; Song SK; Zhao P; Wei LM; Jiao HS Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954 [TBL] [Abstract][Full Text] [Related]
22. Release of bovine serum albumin from preformed porous microspheres of poly(L-lactic acid). Puri N; Jones AB; Kou JH; Wyandt CM J Microencapsul; 2000; 17(2):207-14. PubMed ID: 10738696 [TBL] [Abstract][Full Text] [Related]
23. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Feng R; Zhang Z; Li Z; Huang G Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001 [TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. Uchida T; Yoshida K; Goto S J Microencapsul; 1996; 13(2):219-28. PubMed ID: 8999126 [TBL] [Abstract][Full Text] [Related]
25. Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiation. Fernández-Carballido A; Puebla P; Herrero-Vanrell R; Pastoriza P Int J Pharm; 2006 Apr; 313(1-2):129-35. PubMed ID: 16495023 [TBL] [Abstract][Full Text] [Related]
26. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
27. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres. Sansdrap P; Moës AJ J Microencapsul; 1998; 15(5):545-53. PubMed ID: 9743911 [TBL] [Abstract][Full Text] [Related]
28. Nanostructured microspheres produced by supercritical fluid extraction of emulsions. Della Porta G; Reverchon E Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122 [TBL] [Abstract][Full Text] [Related]
29. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. Rawat M; Saraf S; Saraf S AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537 [TBL] [Abstract][Full Text] [Related]
30. Surface drug removal from ibuprofen-loaded PLA microspheres. Leo E; Forni F; Bernabei MT Int J Pharm; 2000 Feb; 196(1):1-9. PubMed ID: 10675702 [TBL] [Abstract][Full Text] [Related]
31. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics. Wakiyama N; Juni K; Nakano M Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2621-8. PubMed ID: 7139823 [No Abstract] [Full Text] [Related]
32. Composite microparticles with in vivo reduction of the burst release effect. Sheikh Hassan A; Sapin A; Lamprecht A; Emond E; El Ghazouani F; Maincent P Eur J Pharm Biopharm; 2009 Nov; 73(3):337-44. PubMed ID: 19651210 [TBL] [Abstract][Full Text] [Related]
33. In vitro study of GDNF release from biodegradable PLGA microspheres. Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458 [TBL] [Abstract][Full Text] [Related]
34. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348 [TBL] [Abstract][Full Text] [Related]
35. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation. Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299 [TBL] [Abstract][Full Text] [Related]
36. [Study on the rifampicin polylactic acid microspheres for lung targeting]. Zhang W; Jiang X; Zhu C; Hu J Yao Xue Xue Bao; 1998; 33(1):57-61. PubMed ID: 11938937 [TBL] [Abstract][Full Text] [Related]
37. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain. Reza MS; Whateley TL J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956 [TBL] [Abstract][Full Text] [Related]
38. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
39. Low molecular weight polylactic acid as a matrix for the delayed release of pesticides. Zhao J; Wilkins RM J Agric Food Chem; 2005 May; 53(10):4076-82. PubMed ID: 15884842 [TBL] [Abstract][Full Text] [Related]
40. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]